Posted by Michael Wonder on 27 Feb 2019
EMA publishes agenda for 25-28 February 2019 CHMP meeting
25 February 2019 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Zanamavir
- Lorlatinib
- Andexanet alfa
- Pegvaliase
- Paclitaxel
- Rizankizumab
- Volanesorsen
- Sotigliflozin
